New therapeutic approaches for genetic skeletal disorders [ 1/1/2021 - 12/31/2023 ]

Research Grant

Brief description Genetic skeletal disorders are a significant disease burden with limited therapeutic options. We will use mouse models of cartilage and bone disorders and human induced pluripotent stem cell derived bone and cartilage 'disease in a dish' models to test repurposed FDA-approved drugs and new drug candidates as novel therapeutic strategies.

Funding Amount $961,150

Funding Scheme Ideas Grants

Chief Investigator A/Pr Shireen Lamande

Notes Ideas Grants